Literature DB >> 26508409

Intracranial Meningiomas: A 30-Year Experience and Literature Review.

H Maximilian Mehdorn1.   

Abstract

Intracranial meningiomas are tumors arising from the covering cells of the arachnoid layer of the dura mater or from the intraventricular choroid plexus. While mostly benign tumors, they still represent a major challenge to neurosurgeons and other medical disciplines involved in their diagnostic and therapeutic management. Although this review intends to give some state-of-the-art information from the literature, it is mainly based on personal experiences since more than 30 years caring for more than 1500 meningioma patients and point to a few new strategies to further improve on patient outcome.Diagnostics are based on magnetic resonance imaging which shows the relationship between tumor and surrounding intracranial structures, particularly the brain but also the vasculature and to some extent the cranial nerves. Furthermore, it may suggest the grading of the tumor and is very helpful in the postoperative diagnosis of complications and later follow-up course.Surgery still is the main treatment with the aim to completely remove the tumor; also in cases of recurrence, other additional options include radiotherapy and radiosurgery for incompletely removed or recurrent meningiomas. Postoperative chemotherapy has not been shown to provide substantial benefit to the patient especially in highly malignant meningiomas.All therapy options should be intended to provide the patient with the best possible functional outcome. Patients' perspective is not always equivalent to surgeons' perspectives. Neuropsychological evaluation and additional guidance of patients harboring meningiomas have proven to be important in modern neurosurgical intracranial tumor treatment. Their help beyond neurosurgical care facilitates the patients to lead an independent postoperative life.

Entities:  

Keywords:  Intracranial meningioma; Magnetic resonance imaging; Neuropsychology; Surgery

Mesh:

Year:  2016        PMID: 26508409     DOI: 10.1007/978-3-319-21359-0_6

Source DB:  PubMed          Journal:  Adv Tech Stand Neurosurg        ISSN: 0095-4829


  2 in total

1.  Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.

Authors:  Leland Rogers; Peixin Zhang; Michael A Vogelbaum; Arie Perry; Lynn S Ashby; Jignesh M Modi; Anthony M Alleman; James Galvin; David Brachman; Joseph M Jenrette; John De Groot; Joseph A Bovi; Maria Werner-Wasik; Jonathan P S Knisely; Minesh P Mehta
Journal:  J Neurosurg       Date:  2017-10-06       Impact factor: 5.115

2.  Risks and neurological benefits of meningioma surgery in elderly patients compared to young patients.

Authors:  Hajrullah Ahmeti; Christoph Borzikowsky; Dieter Hollander; Christoph Röcken; Olav Jansen; Michael Synowitz; Maximilian H Mehdorn
Journal:  J Neurooncol       Date:  2021-09-01       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.